Ian F. Smith, EVP, COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 74,800 shares at $142.40 ($10.8M) on 2017-10-31, disclosed to the SEC on 2017-10-31.
Open-market sale of $10.8M VRTX by EVP, COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $142.40 | 1,700 | $242K | 2.2% |
| 2 | $143.47 | 5,200 | $746K | 6.9% |
| 3 | $144.47 | 32,945 | $4.8M | 43.9% |
| 4 | $145.26 | 22,464 | $3.3M | 30.1% |
| 5 | $146.39 | 5,200 | $761K | 7.0% |
| 6 | $147.40 | 3,500 |
| $516K |
| 4.8% |
| 7 | $148.26 | 3,791 | $562K | 5.2% |
| Total | $145.05 avg | 74,800 | $10.8M | 100% |
| Filing → |
| ACOR | SELL | 2018-06-19 | $786K | — | Filing → |
| VRTX | SELL | 2018-05-15 | $635K | — | Filing → |
| ACOR | SELL | 2018-05-04 | $237K | — | Filing → |